Skip to content
Physician-led · 50 states
MON ÉLAN
GIP + GLP-1 receptor agonist

Mounjaro

tirzepatide

FDA-approved for type-2 diabetes management. Once-weekly subcutaneous injection.

Mechanism

How it works

Mounjaro is the same molecule as Zepbound (tirzepatide), but its FDA approval is for type-2 diabetes rather than chronic weight management. It activates GIP and GLP-1 receptors to improve glucose control and reduce appetite.

Technical detail
Tirzepatide is a dual GIP/GLP-1 receptor agonist. In type-2 diabetes, the combined incretin signal produces glucose-dependent insulin release and glucagon suppression, contributing to HbA1c reduction.
At Mon Élan

How we use it

Mounjaro is prescribed within the GLP-1 Weight Optimization program for patients with type-2 diabetes whose physician determines it is the appropriate FDA-approved option. We do not market Mounjaro for weight loss — that indication belongs to Zepbound. Continuity is a priority — you will see the same physician whenever clinically possible.

Route & titration

What to expect

Once-weekly subcutaneous self-administered injection. Dose escalation per the diabetes label: 2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg, advancing approximately monthly per tolerance and glycemic response.

Safety

Adverse effects and contraindications

Common
  • Nausea during titration
  • Diarrhea
  • Constipation
  • Reduced appetite
Infrequent
  • Headache
  • Injection-site irritation
Serious
  • Pancreatitis — discontinue if suspected
  • Gallbladder events
  • Hypoglycemia when used in combination with insulin or a sulfonylurea
  • Thyroid C-cell tumors — boxed warning per the FDA label
Contraindications
  • Personal or family history of medullary thyroid carcinoma or MEN-2 syndrome
  • Pregnancy or planned pregnancy in the next 2 months
  • Severe gastroparesis
Evidence

What the literature says

Published trials of tirzepatide in type-2 diabetes (the SURPASS program) report HbA1c reduction and weight reduction. Mon Élan does not claim specific outcomes for any patient.

Dispensing

How it reaches you

Branded Mounjaro is prescribed and dispensed via a separately licensed retail/specialty pharmacy partner at the dispensing pharmacy's published cash price; the exact figure is pulled at each visit and surfaced in your portal before you authorize routing. Mon Élan does not add a markup to medication.

HIPAA Compliant
Texas Medical Board · Licensed Physicians
Licensed Pharmacy · Partner
No insurance billing · FSA / HSA eligible

Begin a documented physician visit.

Prescribing is the outcome of a clinical encounter, not a checkout flow. Your assessment takes about eight minutes; nothing is billed until you and your physician agree on a protocol.

Begin assessment

Eight minutes to start. A lifetime of difference.

A Mon Élan-affiliated physician reviews your case within 24 hours. No insurance billed. Cancel anytime, two taps.